Literature DB >> 3812528

Euthyroid pretibial myxedema.

J J Chen, P W Ladenson.   

Abstract

Pretibial myxedema is typically associated with clinical hyperthyroidism, diffuse goiter, and ophthalmopathy in patients with Graves' disease. A case of biopsy-proved pretibial myxedema was encountered in a clinically euthyroid woman who had neither diffuse goiter nor exophthalmos. Although serum total and free thyroxine hormone concentrations were normal, the thyroid-stimulating hormone response to thyrotropin-releasing hormone was absent. This case illustrates that pretibial myxedema may present without other more common manifestations of Graves' disease. In patients with suspect pretibial skin lesions, the thyrotropin-releasing hormone stimulation test may be required to establish the presence of subtle underlying thyroid gland autonomy and the diagnosis of euthyroid pretibial myxedema.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3812528     DOI: 10.1016/0002-9343(87)90077-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Radiation therapy as part of the therapeutic regimen for extensive multilocular myxedema in a patient with exophthalmos, myxedema and osteoarthropathy syndrome: A case report.

Authors:  Khaled Elsayad; Jan Kriz; Julia Bauch; Sergiu Scobioala; Uwe Haverkamp; Cord Sunderkötter; Hans Theodor Eich
Journal:  Oncol Lett       Date:  2015-02-26       Impact factor: 2.967

2.  Pretibial Myxedema in a Euthyroid Patient.

Authors:  Stephen Ansah-Addo; Andrew F Alexis
Journal:  J Clin Aesthet Dermatol       Date:  2021-01-01

3.  Pretibial mucinosis in an euthyroid patient.

Authors:  Laura de Mattos Milman; Aline Barcellos Grill; Giana Paula Müller; Damiê De Villa; Paulo Ricardo Martins Souza
Journal:  An Bras Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.896

4.  Elephantiasic Graves' Dermopathy in a Patient with Negative Thyroid-Receptor Auto-Antibodies.

Authors:  Agnethe Berglund; Jette Lindorff Riis; Niels Henrik Vinther Krarup; Eva Spaun; Eva Ebbehøj
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.